American Healthcare REIT, Inc. (AHR)
NYSE:AHR
AHR Stock Chart & Stats
$47.16
$0.54(1.95%)
At close: 4:00 PM EST
$47.16
$0.54(1.95%)
Day’s Range― - ―
52-Week Range$26.48 - $54.67
Previous CloseN/A
Volume219.06K
Average Volume (3M)2.67M
Market Cap
$8.96B
Enterprise Value$10.41B
Total Cash (Recent Filing)$114.84M
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)111.9
Beta0.64
Next Earnings
May 18, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend Yield2.1%
Share Statistics
EPS (TTM)0.06
Shares Outstanding188,028,550
10 Day Avg. Volume2,759,708
30 Day Avg. Volume2,667,976
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)2.35
Price to Sales (P/S)3.46
P/FCF Ratio47.11
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue4.61
Enterprise Value/Gross Profit30.29
Enterprise Value/Ebitda32.45
Forecast
1Y Price Target
$57.67Price Target Upside22.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.77
Revenue Forecast (FY)$2.63B
Bulls Say, Bears Say
Bulls Say
Acquisition-driven GrowthAnalyst expects meaningful external growth through acquisitions supported by a favorable cost of capital, which could drive earnings upside if high-quality properties and operators are acquired.
SHOP Performance And RIDEA ExposureAnalyst notes specialty operating segments reported robust same-store net operating income growth and elevated RIDEA exposure, which should support core performance and regional operating leverage.
Trilogy Asset QualityAnalyst highlights Trilogy's above-average quality metrics and high facility ratings, supporting higher occupancy and stronger negotiating power with payers to improve revenue.
Bears Say
Acquisition Execution And Market CompetitionAnalyst warns that a more competitive market for SHOP transactions and poor acquisition execution could make growing through deals more challenging and undermine expected earnings accretion.
Regulatory And Reimbursement RiskAnalyst warns that deterioration in federal reimbursement or regulatory conditions for skilled nursing or senior housing, including pressures in Medicare Advantage and Medicaid, could materially reduce revenues.
Triple-net Income WeaknessAnalyst notes triple-net property income showed only modest improvement, which could limit overall portfolio momentum and constrain near-term cash flow growth.
American Healthcare REIT, Inc. News
AHR FAQ
What was American Healthcare REIT, Inc.’s price range in the past 12 months?
American Healthcare REIT, Inc. lowest stock price was $26.48 and its highest was $54.67 in the past 12 months.
What is American Healthcare REIT, Inc.’s market cap?
American Healthcare REIT, Inc.’s market cap is $8.96B.
When is American Healthcare REIT, Inc.’s upcoming earnings report date?
American Healthcare REIT, Inc.’s upcoming earnings report date is May 18, 2026 which is in 46 days.
How were American Healthcare REIT, Inc.’s earnings last quarter?
American Healthcare REIT, Inc. released its earnings results on Feb 26, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.155 by -$0.095.
Is American Healthcare REIT, Inc. overvalued?
According to Wall Street analysts American Healthcare REIT, Inc.’s price is currently Undervalued.
Does American Healthcare REIT, Inc. pay dividends?
American Healthcare REIT, Inc. pays a Quarterly dividend of $0.25 which represents an annual dividend yield of 2.1%. See more information on American Healthcare REIT, Inc. dividends here
What is American Healthcare REIT, Inc.’s EPS estimate?
American Healthcare REIT, Inc.’s EPS estimate is 0.16.
How many shares outstanding does American Healthcare REIT, Inc. have?
American Healthcare REIT, Inc. has 188,028,550 shares outstanding.
What happened to American Healthcare REIT, Inc.’s price movement after its last earnings report?
American Healthcare REIT, Inc. reported an EPS of $0.06 in its last earnings report, missing expectations of $0.155. Following the earnings report the stock price went down -1.786%.
Which hedge fund is a major shareholder of American Healthcare REIT, Inc.?
Currently, no hedge funds are holding shares in AHR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
American Healthcare REIT, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$57.67 (22.29% Upside)
$57.67 (22.29% Upside)
Blogger Sentiment
Bullish
AHR Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 192.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
57.53%
12-Months-Change
Fundamentals
Return on Equity
2.61%
Trailing 12-Months
Asset Growth
20.90%
Trailing 12-Months
Company Description
American Healthcare REIT, Inc.
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
AHR Company Deck
AHR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum and financial results: double-digit same-store NOI growth across the portfolio in 2025, significant NFFO-per-share growth (22% YoY), active accretive acquisition activity (~$950M in 2025) and constructive 2026 guidance (NFFO $1.99–$2.05). Management emphasized continuity of strategy and several durable tailwinds (occupancy gains, improved payer mix, margin expansion, limited new supply). Key risks discussed were a measured deceleration in same-store growth from 2025 highs to 2026 guidance ranges, early-stage rollout of revenue-management initiatives, increased transaction competition and certain execution/leverage caveats (unsettled forward equity). On balance, the positive operational and capital markets execution substantially outweigh the manageable risks.View all AHR earnings summariesAHR Stock 12 Month Forecast
Average Price Target
$57.67
▲(22.29% Upside)
Technical Analysis
National Health Investors
―
Omega Healthcare
―
Sabra Healthcare REIT
―
Healthcare Realty Trust
―
CareTrust REIT
―
Ownership Overview
0.70% Insiders
24.67% Mutual Funds
15.15% Other Institutional Investors
32.45% Public Companies and Individual Investors